We are live on ! Find out more
Wells Fargo

Wells Fargo Portfolio holdings

AUM $530B
1-Year Est. Return 22.01%
 

Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.

This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+22.01%
3 Year Est. Return
+63.17%
5 Year Est. Return
+74.8%
10 Year Est. Return
+385.76%
AUM
$415B
AUM Growth
+$31.8B
Cap. Flow
+$3.6B
Cap. Flow %
0.87%
Top 10 Hldgs %
19.01%
Holding
7,849
New
356
Increased
3,866
Reduced
2,176
Closed
456

Sector Composition

Rank Sector Weight
1 Technology 14.37%
2 Financials 7.47%
3 Healthcare 7.23%
4 Industrials 6.4%
5 Consumer Discretionary 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPT
7626
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-27,365
Closed -$351K
AEY
7627
DELISTED
ADDvantage Technologies Group
AEY
-7
Closed -$17
CANO
7628
DELISTED
Cano Health, Inc.
CANO
-841
Closed -$4.94K
CYTO
7629
DELISTED
Altamira Therapeutics Ltd
CYTO
-1
Closed -$3
HARP
7630
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-181
Closed -$2.06K
ARVL
7631
DELISTED
Arrival Ordinary Shares
ARVL
-862
Closed -$983
AGRX
7632
DELISTED
Agile Therapeutics
AGRX
-19
Closed -$37
EAR
7633
DELISTED
Eargo, Inc. Common Stock
EAR
-1,036
Closed -$2.68K
PBLA
7634
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
-2
Closed -$36
NVIV
7635
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
-24
Closed -$18
EGPT
7636
DELISTED
VanEck Egypt Index ETF
EGPT
-1
Closed -$14
DISH
7637
DELISTED
DISH Network Corp.
DISH
-244,959
Closed -$1.41M
CHIM
7638
DELISTED
Global X MSCI China Materials ETF
CHIM
-1
Closed -$9
TIO
7639
DELISTED
Tingo Group, Inc. Common Stock
TIO
-34,177
Closed -$23.6K
DOC
7640
DELISTED
PHYSICIANS REALTY TRUST
DOC
-93,702
Closed -$1.25M
CN
7641
DELISTED
Xtrackers MSCI All China Equity ETF
CN
-1
Closed -$21
INTZ
7642
DELISTED
INTRUSION INC NEW
INTZ
-3,858
Closed -$976

Similar funds

Wells Fargo's Q1 2024 Portfolio in Review

As of Q1 2024, Wells Fargo held 7,849 positions worth $415B, up 8.3% from $383B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Wells Fargo's Q1 2024 filing shows 356 new, 3,866 increased, 2,176 reduced and 456 closed positions. Its largest new stake was FT Vest US Equity Buffer ETF July: 970,130 shares worth $43.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.03B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

  • Wells Fargo's largest Q1 2024 buy was FT Vest US Equity Buffer ETF July: 970,130 shares worth $43.1M.
  • Wells Fargo added most to Starbucks in Q1 2024, an estimated $853M increase.
  • Wells Fargo's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.03B.
  • Wells Fargo fully exited Splunk Inc in Q1 2024, selling an estimated $43.1M.
  • Wells Fargo's ten largest holdings make up 19% of its $415B portfolio in Q1 2024.
  • Wells Fargo opened 356 new positions and closed 456 in Q1 2024.
  • Wells Fargo's portfolio value rose 8.3% quarter-over-quarter to $415B.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.